- Joined
- Sep 28, 2017
- Messages
- 116
- Reaction score
- 48
In reviewing paperwork for a new patient I have coming in, I discovered this patient has been receiving Klonopin for at least the past 5 years (possibly longer, but our state database doesn't go back further), when the patient was only 14 years old. And according to the paperwork she completed, she tried Zoloft in 2014 but since then has only been on Klonopin, and according to the database it appears the dose and quantity have gradually increased over the years.
On top of this, the patient reports drinking alcohol multiple days per week (and she's only 19), and she uses marijuana occasionally. (Perhaps not surprisingly, there is a family history of drug and alcohol abuse in both of her parents, too.)
Obviously, this patient has been mismanaged for quite a while and it's up to me to clean up the mess. I plan to start tapering off the Klonopin, especially due to the risks associated with concurrent alcohol and marijuana use, although I don't want to taper too quickly, either.
In the past I've dealt with a patient who had a history of substance use and was still drinking alcohol regularly, and he was very clearly seeking for Klonopin, though wasn't on it; I tried every alternative I could think of with him, and he eventually stopped coming to see me because I wasn't giving him Klonopin.
I'm just curious, for those who may have more experience treating patients who drink regularly, aside from encouraging them to abstain from alcohol, do you check labs such as CDT or GGT to ensure the patient is no longer drinking? Aside from checking a random urine drug screen as part of the treatment agreement, I'm wondering if I should also get some kind of random alcohol screen.
On top of this, the patient reports drinking alcohol multiple days per week (and she's only 19), and she uses marijuana occasionally. (Perhaps not surprisingly, there is a family history of drug and alcohol abuse in both of her parents, too.)
Obviously, this patient has been mismanaged for quite a while and it's up to me to clean up the mess. I plan to start tapering off the Klonopin, especially due to the risks associated with concurrent alcohol and marijuana use, although I don't want to taper too quickly, either.
In the past I've dealt with a patient who had a history of substance use and was still drinking alcohol regularly, and he was very clearly seeking for Klonopin, though wasn't on it; I tried every alternative I could think of with him, and he eventually stopped coming to see me because I wasn't giving him Klonopin.
I'm just curious, for those who may have more experience treating patients who drink regularly, aside from encouraging them to abstain from alcohol, do you check labs such as CDT or GGT to ensure the patient is no longer drinking? Aside from checking a random urine drug screen as part of the treatment agreement, I'm wondering if I should also get some kind of random alcohol screen.